Deoxymethoxetamine

Deoxymethoxetamine (DMXE) is a dissociative anesthetic and a member of the arylcyclohexylamine class of compounds. It is chemically related to methoxetamine (MXE) and is known for its NMDA receptor antagonist properties.
Chemical Structure and Properties[edit]
Deoxymethoxetamine is structurally similar to methoxetamine, with the primary difference being the absence of a methoxy group. The chemical structure of DMXE is characterized by a cyclohexane ring bound to an aryl group and an amine group, which is typical of arylcyclohexylamines.
Pharmacology[edit]
DMXE acts primarily as an NMDA receptor antagonist, which leads to its dissociative effects. By inhibiting the NMDA receptor, DMXE disrupts the normal function of the glutamate neurotransmitter system, which is crucial for synaptic plasticity and memory function.
Effects[edit]
The effects of DMXE are similar to those of other dissociative anesthetics, such as ketamine and methoxetamine. Users report feelings of detachment from the environment and self, altered sensory perceptions, and euphoria. The intensity and duration of these effects can vary based on dosage and individual metabolism.
Legal Status[edit]
The legal status of DMXE varies by country. In some jurisdictions, it may be classified as a controlled substance due to its potential for abuse and lack of medical use. It is important to consult local regulations to determine the legal status of DMXE in a specific area.
Related Compounds[edit]
- Methoxetamine (MXE)
- Ketamine
- Phencyclidine (PCP)
See Also[edit]
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian